KaloBios Investor Settlement Hints At Kaye Scholer Suit
Investors who accuse KaloBios Pharmaceuticals Inc. of concealing criminal investigations into former CEO Martin Shkreli are in line to receive a cut of any proceeds the company gets in a potential...To view the full article, register now.
Already a subscriber? Click here to view full article